Your health and wellness news from Colorado

Provided by AGP

Got News to Share?

Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

Press releases published on March 20, 2026

New Research Strengthens the Link Between Oral Health and Systemic Disease
Aesthetic AF Launches Regenerative Skin Programs in Denver
Cearvol Introduces Wave, the Smart OTC Hearing Aid with Touchscreen Recognized at CES 2026
Publication relating to transparency notifications
Publication relative à des notifications de transparence
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Garaherb Claims Evaluated: Complete Scientific Investigation of Ingredients' Effectiveness
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
XTL Biopharmaceuticals Announces ADS Ratio Change
argenx announces Annual General Meeting of Shareholders on May 6, 2026
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Akemi Detox Tea Claims Evaluated: Investigating Natural Ingredients to Burn Fat and Boost Energy Support
Purisaki Deep Cleansing Foot Pads Claims Evaluated: The 2-in-1 MultiVitamin Detox Patch for Therapeutic Support
ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider
Connected Launches AI-Powered Couples App to Help Partners Improve Communication and Strengthen Relationships
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
SafeSpace Global Corporation Reports Q2 Fiscal 2026 Financial Results; Company Transitions from Pre-Revenue to Revenue-Generating Stage, Expands Footprint with Nashville Office, and Initiates Steps Toward National Exchange Uplisting
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Share us

on your social networks:

Sign up for:

Colorado Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.